Advertisement

CHEST 2022


  • Physicians must do the work to dismantle systemic racism in medicine

    Physicians must do the work to dismantle systemic racism in medicine

    Nneka Sederstrom, PhD, MPH, MA, FCCP, addressed the past and present of racism in medicine during the Richard S. Irwin, MD, Master FCCP, Honor Lecture on Tuesday, October 18.


  • Panelists scrutinize controversial, evolving treatment guidance for VTE

    Panelists scrutinize controversial, evolving treatment guidance for VTE

    Parth Rali, MD, reviewed the latest guidance on the role of catheter-directed thrombolysis in treating patients with VTE during a session on Wednesday, October 19.


  • Session highlights latest understanding of COPD, management strategies

    Session highlights latest understanding of COPD, management strategies

    MeiLan K. Han, MD, MS, offered insight into an updated report on strategies for the diagnosis, management, and prevention of COPD during a session Monday, October 17.


  • Experts review questions surrounding interstitial lung abnormalities

    Experts review questions surrounding interstitial lung abnormalities

    Sean J. Callahan, MD, provided an overview of incidental interstitial lung abnormalities and why clinicians should care during a session Monday, October 17.


  • Share your research with the chest medicine community at CHEST 2023

    Share your research with the chest medicine community at CHEST 2023

    Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented. Be a part of the next group of presenters at CHEST 2023.


  • Shared decision-making and effective communication can help with life support decisions

    Shared decision-making and effective communication can help with life support decisions

    Holly Keyt, MD, FCCP, helped explore the clinical and ethical considerations involved in the management of patients on extracorporeal life support during a session on Tuesday, October 18.


  • Minimally invasive biopsies for sequencing and staging are key to personalized lung cancer treatment

    Minimally invasive biopsies for sequencing and staging are key to personalized lung cancer treatment

    Raymond U. Osarogiagbon, MBBS, offered his insights during a panel discussion on diagnostic lung cancer evaluation, Monday, October 17.


  • Investigators highlight research into long COVID

    Investigators highlight research into long COVID

    Marjan Islam, MD, discussed the use of thoracic ultrasound to evaluate survivors of severe COVID-19 pneumonia during an investigations session on post-COVID syndrome, Sunday, October 16.


  • Streamlining needed to address barriers to diagnosis, treatment for COPD and OSA

    Streamlining needed to address barriers to diagnosis, treatment for COPD and OSA

    Lucas Donovan, MD, MS, highlighted challenges and solutions to the diagnosis and care of COPD and OSA, including the overlap of the two diseases, during a session on Sunday, October 16.


  • Access curated CHEST 2022 content relevant to your interests and practice with Education Spotlights

    Access curated CHEST 2022 content relevant to your interests and practice with Education Spotlights

    Each Spotlight offers a curated selection of CHEST 2022 session recordings on a particular clinical topic, like cystic fibrosis, interstitial lung disease, and severe asthma, offering a straightforward path to expanding your expertise.